Nebivolol Medreg

Nebivolol, the active ingredient in Nebivolol Medreg, is a beta blocker presented as an oral dosage form for oral use. It is used to treat hypertension and heart failure in adult patients. GNH USA supplies Nebivolol Medreg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol acts on the cardiovascular system to control blood pressure and improve cardiac function. - Hypertension: lowers systolic and diastolic blood pressure by reducing heart rate and peripheral resistance. - Heart failure: improves left‑ventricular ejection fraction and reduces symptoms of fluid overload.

Nebivolol may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate pain in the head region. - Dizziness: sensation of light‑headedness, especially on standing. - Fatigue: unusual tiredness or lack of energy. - Bradycardia: slower than normal heart rate. - Nausea: feeling of stomach upset.

Serious or Rare Side Effects: - Severe bradycardia: markedly low heart rate requiring medical attention. - Hypotension: dangerously low blood pressure. - Heart block: impaired electrical conduction in the heart. - Bronchospasm: narrowing of airways, especially in asthmatic patients. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

Nebivolol requires careful monitoring in several clinical situations. - Monitor blood pressure: ensure target values are achieved without excessive drop. - Assess cardiac function: evaluate heart rate and ECG for conduction abnormalities. - Use caution in asthma or COPD: β‑blockade may exacerbate bronchospasm. - Avoid abrupt discontinuation: taper dose to prevent rebound hypertension. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nebivolol can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Other beta blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): increased risk of AV block. - Clonidine: enhanced hypotensive effect.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: additive blood‑pressure lowering. - Diuretics: potential electrolyte disturbances. - NSAIDs: may reduce antihypertensive effect of nebivolol.